CLINICAL_TRIALS
trial_result
· 2018-07-02
Clinical Trial Update: A Study of AK0529 in Infants Hospitalized With RSV [Phase 1]
Summary
A Phase 1 trial of the RSV therapy AK0529 in infants hospitalized with Respiratory Syncytial Virus infections was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: TERMINATED